Validating Gulf War Illness Blood Biomarkers
NCT05736146
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
The investigators goals are to identify blood lipids/metabolites that correlate with cognitive decline in the presence of the APOE ε4 allele among veterans with GWI. To determine the effect of dietary, medical and biological factors that influence lipid and metabolites in blood from GW veterans. To identify blood lipid/metabolite profiles that correlate with bioenergetics deficits and glial activation in the brains of GWI. To validate blood biomarker signatures of GWI using APOE genotyping and blood lipids/metabolites that correlate with the CNS dysfunction in GWI.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Gulf War Syndrome
- Gulf War Illness
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 35 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Roskamp Institute Inc.
- Last updated on ClinicalTrials.gov
- July 24, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Palto Alto Veterans Institute for Research · Palo Alto, CA
Florida · 1
- The Roskamp Institute · Sarasota, FL
Massachusetts · 1
- Boston University · Boston, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.